Assessment and management of chronic pain in the older adult

Journal of the American Pharmacists Association

Volumn 50, Issue 3, 2010, Pages

  Cooper, James W ^a,b   Burfield, Allison H ^c  

^a UNIVERSITY OF GEORGIA   (United States)

^b MEDICAL COLLEGE OF GEORGIA   (United States)

^c UNIVERSITY OF NORTH CAROLINA AT CHARLOTTE   (United States)

Author keywords

Adverse drug effects; Elderly; Medication management; Opioid analgesics; Pain (chronic); Pain management

Indexed keywords

ANALGESIC AGENT;

ACUTE DISEASE; AGED; ARTICLE; CHRONIC DISEASE; FEMALE; GERIATRIC ASSESSMENT; HUMAN; MALE; METHODOLOGY; PAIN; PAIN ASSESSMENT; PRACTICE GUIDELINE;

ACUTE DISEASE; AGED; AGED, 80 AND OVER; ANALGESICS; CHRONIC DISEASE; FEMALE; GERIATRIC ASSESSMENT; HUMANS; MALE; PAIN; PAIN MEASUREMENT; PRACTICE GUIDELINES AS TOPIC;

EID: 77955300775     PISSN: 15443191     EISSN: 15443450     Source Type: Journal    
DOI: 10.1331/JAPhA.2010.10028     Document Type: Review

References (30)

1. Cooper JW, Burfield AH. Pain management in "geriatric drug management." Accessed at www.cooperconsultantpress.com, April 14, 2010.
2. Molony SL, Kobayashi M, Holleran EA, Mezey M. Assessing pain as a fifth vital sign in long-term care facilities: recommendations from the field. J Gerontol Nurs. 2005;31:16-24.
3. Davis MP, Srivastava M. Demographics, assessment and management of pain in the elderly. Drugs Aging. 2003;20:23-57.
4. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189-98.
5. Reisberg B, Ferris SH, deLeon MJ, Crook T. The global deterioration scale for assessment of primary degenerative dementia. Am J Psychiatry. 1982;139:1136-9.
6. National Institute of Mental Health. Abnormal involuntary movement scale. In Guy W, Ed. ECDEU assessment manual for psychopharmacology. DHEW publ. no 76-338. Rockville, MD: National Institute of Mental Health; 1976:534-7.
7. Douzjian M, Wilson C, Schults M, et al. A program to use pain control medication to reduce psychotropic drug use in residents with difficult behavior. Ann Longterm Care. 1998;6(5):174-8.
8. Fick DM, Cooper JW, Wade WE, et al. Updating the Beers criteria for potentially inappropriate medication use in older adults. Arch Intern Med. 2003;163:2716-24.
9. AGS Panel on Pharmacological Management of Persistent Pain in Older Persons. Pharmacological management of persistent pain in older persons. Accessed at www.americangeriatrics.org/education/final-recommendations.pdf, July 3, 2009.
10. Lee YH, Woo JH, Choi SJ, et al. Effect of glucosamine or chondroitin sulfate on the osteoarthritis progression: a meta-analysis. Rheumatol Int. 2010;30:357-63.
11. Food and Drug Administration. Recommendations for FDA interventions to decrease the occurrence of acetaminophen hepatotoxicity. Accessed at www.fda.gov/downloads/AdvisoryCommittees/.../Drugs/.../UCM164898.pdf, May 29, 2009.
12. Cooper JW, Wade WE, Mallet L. Anemia detection and treatment in a four geriatric long term care facility population. Journal of Pharmacoepidemiology. 1990;1(1):61-70.
13. Cooper JW. Chronic constipation associations and laxative efficacy in a geriatric nursing home population. Journal of Pharmacoepidemiology. 1991;1(3-4):29-40.
14. American Hospital Formulary Service. Drug information 2008;1971, 2234.
15. Cooper JW. Consultant pharmacist effect on NSAID costs and gastropathy over a 5-year period. Consult Pharm. 1997;12:792-6.
16. Cooper JW, Wade WE. Pharmacists interventions in geriatric nursing facility: NSAID therapy. Consult Pharm. 2005;20:492-7.
17. American Hospital Formulary Service. Drug Information. 2008;2115.
18. Eshaghian S, Kaul S, Amin S, et al. Role of clopidogrel in managing atherothrombotic cardiovascular disease. Ann Intern Med. 2007;146:434-41.
19. Page J, Henry D. Consumption of NSAIDs and the development of congestive heart failure in elderly patients: an underrecognized public health problem. Arch Intern Med. 2000;160:777-84.
20. Feenstra J, Heerdink ER, Grobbee DE, et al. Association of non-steroidal anti-inflammatory drugs with first occurrence of heart failure and with relapsing heart failure: the Rotterdam Study. Arch Intern Med. 2002;162:265-70.
21. Visser LE, Graatsma HH, Stricker BH. Contraindicated NSAIDs are frequently prescribed to elderly patients with peptic ulcer disease. Br J Clin Pharmacol. 2002;53:183-8.
22. Fischer LM, Schlienger RG, Matter CM, et al. Discontinuation of nonsteroidal anti-inflammatory drug therapy and risk of acute myocardial infarction. Arch Intern Med. 2004;164:2472-6.
23. Fries JF, Williams CA, Bloch DA, Michel BA. Nonsteroidal anti-inflammatory drug-associated gastropathy: incidence and risk factor models. Am J Med. 1991;91:213-22.
24. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30:239-45.
25. Campbell CL, Smyth S, Montalescot G, Steinhubl SR. Aspirin dose for the prevention of cardiovascular disease: a systematic review. JAMA. 2007;297:2018-24.
26. Boncler M, Gresner P, Nocun M, et al. Elevated cholesterol reduces acetylsalicylic acid-mediated platelet acetylation. Biochim Biophys Acta. 2007;1770:1651-9.
27. Guay DRP. Opioid analgesics for persistent pain in the older patient: part 1. Clin Geriatr. 2010;18(3):37-46.
28. Turner MK, Hooten WM, Schmidt JE, et al. Prevalence and clinical correlates of vitamin D inadequacy among patients with chronic pain. Pain Med. 2008;9:979-84.
29. Straube S, Moore AR, Derry S, McQuay HJ. Vitamin D and chronic pain. Pain. 2009;141:10-3.
30. Kroenke K, Bair MJ, Damush TM, et al. Optimized antidepressant therapy and pain self-management in primary care patients with depression and musculoskeletal pain: a randomized controlled trial. JAMA. 2009;301:2099-110.